Seventy-five per cent of patients had a normal plt count at the end of study.

However, this test had lower sensitivity and specificity than did the donor-specific PLT.

One of its recent high-profile acquisitions was Italy's Parmalat PLT.MI group in 2012.

The ratio of PLT:RBCs was not associated with differences in mortality.

We then assessed whether PLTs were capable of modulating functional aspects of neutrophils.